Correction to: IRF8 as a Novel Marker to Differentiate Between CD30-Positive Large Cell Lymphomas

Am J Clin Pathol. 2023 Nov 22:aqad173. doi: 10.1093/ajcp/aqad173. Online ahead of print.NO ABSTRACTPMID:37991998 | DOI:10.1093/ajcp/aqad173

Source: American Journal of Clinical Pathology - November 22, 2023 Category: Pathology Source Type: research